My Fund Comparison
Initilizing list...
|
Tekla World Healthcare Fund as of
07/01/2022
| NYSE /
THW |
Asset Class:
Sector Equity Funds
|
1 YR Lipper Avg:
-11.97% |
| Growth of $10K |
|
| Avg Annual Total Return % |
| |
10 YR |
5 YR |
1 YR |
YTD |
| Market Return |
-- |
9.90% |
-2.91% |
-5.65% |
| Lipper Pct. Rank |
-- |
14 |
15 |
15 |
|
| NAV Return |
-- |
6.77% |
-6.46% |
-10.70% |
| Lipper Pct. Rank |
-- |
36 |
47 |
43 |
| Premium/Discount History |
|
| Premium/Discount |
| 10 YR Avg |
5 YR Avg |
YTD Avg |
|
-- |
-1.826% |
5.100% |
|
| NAV |
$13.38 |
Market Price |
$14.62 |
| Net Change |
$0.15 |
Market Change |
$0.22 |
| Premium/Discount |
9.27% |
| 1 YR NAV Return |
-6.461% |
| 1 YR NAV Rank |
47 |
| 12-Mo Yield as of
5/31/2022 |
Yield
Def |
| Income Only Yield |
0.53% |
| Distribution Yield (Market) |
8.87% |
| Most Recent Income Dividend |
$0.117 |
| Ex-Div Date |
6/17/2022 |
| Most Recent Cap Gain Dividend |
$0.117 |
| Ex-Div Date |
12/19/2019 |
| Dividend Frequency |
Monthly |
| YTD Dividends |
$0.584 |
| YTD Capital Gains |
-- |
| Inception Date |
6/30/2015 |
| Fund Advisor |
Tekla Capital Management LLC |
| Manager & Tenure |
Team Managed |
| Phone |
800-426-5523 |
| Website |
www.teklacap.com |
| Total Net Assets (mil)
as of
6/30/2022 |
$495.1 |
| % Leveraged Assets
as of
9/30/2021 |
19.14% |
| Portfolio Turnover |
69.00% |
| Mgmt Fees |
1.237% |
| Expense Ratio |
1.740% |
| Fund Objective |
| The Fund seeks current income and long-term capital appreciation. Under normal market conditions, the Fund expects to invest at least 80% of its Managed Assets in U.S. and non-U.S. companies engaged in the healthcare industries including equity securities, convertible securities and debt securities. |
|
| Top Holdings
(as of 3/31/2022) |
|
UnitedHealth Group Inc ORD |
7.71% |
|
Roche Holding AG DR |
5.40% |
|
AstraZeneca PLC DR |
4.61% |
|
Pfizer Inc ORD |
3.91% |
|
Johnson & Johnson ORD |
3.82% |
|
Abbott Laboratories ORD |
3.64% |
|
Abbvie Inc ORD |
3.54% |
|
Novo Nordisk A/S DR |
3.09% |
|
Mckesson Corp ORD |
3.02% |
|
Eli Lilly and Co ORD |
2.73% |
|
| Top Sectors
(as of 3/31/2022) |
|
Health Care |
93.19% |
|
Financials |
5.55% |
|
Consumer Services |
3.63% |
|
Non Classified Equity |
2.10% |
|
Industrials |
2.01% |
|
Technology |
1.14% |
|
|
Resources
Aberdeen Closed-End TV
Asset TV — CEF Channel
CEF Connect
Cohen & Steers CEFs Knowledge Center
Harvest — CEFA Channel
Legg Mason CEFs
Seeking Alpha — CEFA Channel
|
|
Powered by a SySys® data & content management system.
© Thomson Reuters 2019. All rights reserved. Any copying, republication or redistribution of Lipper, a Thomson Reuters company, content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Lipper, a Thomson Reuters company. Lipper, a Thomson Reuters company shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.
|